ProteinSimple Charges Ahead with the Simple Western
Santa Clara, CA, September 12, 2012 — ProteinSimple today introduced Peggy as the next member of the Simple Western product family. Peggy is the first Simple Western product to not only replace the traditional slow, inconsistent Western Blot, but to enable further in-depth characterization of proteins via charge-based separation.
The Simple Western is a Western with none of the hassle. No messy gels, no transfer tanks, no blots, no imaging and no manual analysis. Simply load up to 96 samples, push a button, walk away and come back to fully analyzed data. The system automates everything. Now, with Peggy, the Simple Western system separates proteins by size or charge, detects your target proteins and tells you their molecular weight or pI.
In today's instrumentation market, researchers are forced to choose between platforms that perform individual assays. Peggy eliminates that painful decision by enabling two distinct assays in a single high throughput system. With Peggy, a biopharmaceutical researcher can perform 96 Simple Westerns in a single automated experiment to identify lead candidates and further characterize any heterogeneity in those candidates using Peggy's dual-mode capability. The ability to combine analytical approaches within a single automated instrument is of tremendous value.
“Peggy brings together two critical requirements in biopharmaceutical research, identification and characterization,” commented Tim Harkness, CEO at ProteinSimple. “The dual-mode capability of Peggy will further simplify protein research and we are extremely proud and excited to offer a product that delivers enhanced sample characterization in the fully automated, quantitative format our customers expect from us.”
Meet Peggy and the Simple Western family on October 13-17 at the Society for Neuroscience meeting in New Orleans, Louisiana or visit www.proteinsimple.com.
ProteinSimple's goal is simply to help researchers gain a better understanding of proteins and their role in disease. The Company's strategy is to power protein research by making it simpler and more quantitative, ultimately revealing new insights into the true nature of proteins. ProteinSimple has built a unique portfolio of protein analysis tools including systems for traditional protein imaging, systems to probe the structure and purity of protein based therapeutics and systems that provide fresh insight into protein signaling. ProteinSimple has over 170 employees, more than 10,000 systems installed around the world and is headquartered in Santa Clara, California. For more information, visit www.proteinsimple.com.
CONTACT: John Proctor, Ph.D., Director, Corporate Development, ProteinSimple, (408) 510-5534, firstname.lastname@example.org